Skip to search formSkip to main contentSkip to account menu

AMI 25

Known as: AMI-25, AMI25 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Contrast agents, such as iron oxide, enhance MR images by altering the relaxation times of tissues in which the agent is present… 
Review
1998
Review
1998
Abstract. A variety of parenterally administered iron oxides have been developed for contrast-enhanced MRI of the liver. Two… 
Highly Cited
1996
Highly Cited
1996
PURPOSE To assess AMI-25- versus gadolinium-enhanced magnetic resonance (MR) imaging in the differential diagnosis of liver… 
Highly Cited
1995
Highly Cited
1994
Highly Cited
1994
PURPOSE To evaluate the ability of magnetic resonance (MR) imaging enhanced with AMI-25 to depict and characterize hepatic tumors… 
Highly Cited
1990
Highly Cited
1990
An ultrasmall superparamagnetic iron oxide (USPIO) preparation was developed that is small enough to migrate across the capillary… 
Highly Cited
1990
Highly Cited
1990
We have applied a superparamagnetic iron oxide formulation (AMI‐25, Advanced Magnetics, Inc., Cambridge, MA) to image the… 
Highly Cited
1990
Highly Cited
1990
Previous studies of AMI-25, a particulate iron oxide magnetic resonance contrast agent, imaged liver tumors 1 or more hours after… 
Highly Cited
1989
Highly Cited
1989
The pharmacokinetics (distribution, metabolism, bioavailability, excretion) and toxicity (acute and subacute toxicity…